<DOC>
	<DOCNO>NCT01989364</DOCNO>
	<brief_summary>Background : The Apparent Diffusion Coefficient ( ADC ) acquire Diffusion Weighted Imaging ( DWI-MR ) show correlate cellular density . The ADC indicative Gross Tumour Volume ( GTV ) , preliminary data show dynamic DWI volume treatment ( shrinkage ) well dose DWI volume impact treatment outcome . Hypoxic tumour cell within primary tumour identify prognostic importance local control Tumour hypoxia cause insufficiency tumour vasculature lead chronic diffusion limit acute flow limit hypoxia . Radioresistant hypoxic cell diminish rate local control , hypoxia driven increase metastatic potential tumour lower rate distant disease control . Functional image potential visualise radioresistant tumour subvolumes . PET scan ( 18F-FAZA ) hypothesize visualise hypoxic tumour subvolumes , dynamic contrast enhance ( DCE ) MR image use quantify extent poor perfusion region within cervical tumour . Objectives : Primary : Sensitivity specificity functional imaging ( 18F-FAZA PET ( optional ) , T1w , T2w , DWI-MRI DCE-MRI ) identify tumour good bad response radio-chemotherapy Secondary : Determining whether difference bias centre . The difference bias assess T1 T2 scan Ktrans ADC map .</brief_summary>
	<brief_title>Repetitive Functional Imaging Locally Advanced Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Patients locally advanced cervical cancer FIGO stage IB2IV refer definitive radiochemotherapy . Patients MR guide brachytherapy part standard patient treatment . Patients without previous record allergic reaction infusion protocol relate contrast medium tracer ( Gadoliniumbased MRimaging , FAZA ( perform ) ) Patients sufficient kidney function accord local regulation Patients 18 year age . Cancer uterine cervix consider suitable curative treatment . Positive biopsy show Squamous cell carcinoma , Adeno cell carcinoma , Adeno Squamous cell carcinoma . Staging accord FIGO TNM perform MRI pelvis diagnosis available MRI , CT PETCT retroperitoneum abdomen diagnosis available MRI pelvis applicator Brachytherapy timepoint perform Patient inform consent Patients contra indication MRI FAZAPET ( perform ) Patients active infection severe medical condition Patients pregnant , lactate childbearing potential without adequate contraception . Other primary malignancy Metastatic disease beyond paraaortic region ( L1L2 ) Previous pelvic radiotherapy Previous total partial hysterectomy Combination preoperative radiotherapy surgery Patients receive Brachytherapy Patients receive External Beam radio therapy Patients receive neoadjuvant chemotherapy , hyperthermia antineoplastic treatment approve Embrace study committee Contra indication BT</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>